奈韦拉平相关化合物B

C₁₂H₁₀N₄O

226.23

NA.24

Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards. Nevirapine is found to be the first antiretroviral agent and selective non-competitive inhibitor of the reverse transcriptase, widely used for the treatment of adults and adolescents affected with human immunodeficiency viruses (HIV).

These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements.
Nevirapine may be used as a pharmaceutical reference standard for the quantification of the analyte in pharmaceutical samples using capillary zone electrophoresis method.

These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.

This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.

To see an example of a Certificate of Analysis for this material enter LRAA8554 in the Documents slot below. This is an example certificate only and may not be the lot that you receive.

300

certified reference material
pharmaceutical secondary standard

current certificate can be downloaded

pkg of 50 mg

HPLC: suitable
gas chromatography (GC): suitable

pharmaceutical (small molecule)

neat

traceable to USP 1460736

2-30℃

GHS06

Danger

H301

P301 + P310 + P330

Acute Tox. 3 Oral

6.1D - Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects

WGK 3